LG

Labani Ghosh

Active Director Director DIN 09077989
DIN 09077989 First appointment Mar 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Labani Ghosh

Data last updated:

Labani Ghosh is a Director at Kronicure Biosciences Private Limited (since 2021). The company operates in Chemicals. Kronicure Biosciences Private Limited reported revenue of ₹3.36 Cr (FY 2025).

DIN 09077989
Primary Designation Director
Industry Chemicals
First Appointment 03 Mar 2021
Oldest Company Age 6 yrs
Largest company Kronicure Biosciences Private Limited · ₹3.36 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Mar 20212020₹3.36 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Kronicure Biosciences Private Limited
Premium access

Shareholding and investment profile for Labani Ghosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Labani Ghosh

Labani Ghosh currently holds 1 directorship: Kronicure Biosciences Private Limited (Director, since 03 Mar 2021, revenue ₹3.36 Cr (FY 2025)).

Labani Ghosh was first appointed on 03 Mar 2021 as Director at Kronicure Biosciences Private Limited.

The current boards of Labani Ghosh's companies include Mira Mamata Pattanaik (Kronicure Biosciences Private Limited), Pronami Borah (Kronicure Biosciences Private Limited), Satyendra Nath Chakraborty (Kronicure Biosciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available